Thank you for having joined us at ITOC8!

Note: Access for registered participants only until November 9, 2021.

Registration was possible until October 9, 2021 and is no longer possible.

Save the Dates

9th Immunotherapy of Cancer Conference

September 22 - 24, 2022

Munich, Germany

ITOC9_Logo_2021_180dpi_RGB.png

While we are preparing for ITOC9, we invite you to review the
Lifetime Achievement Award Session of ITOC8
ITOC8 Lifetime Achievement Award presented to Uğur Şahin and Özlem Türeci BioNTech SE, Mainz, Germany
"Translating the success of the mRNA vaccine to cancer"

About ITOC

The Immunotherapy of Cancer Conference (ITOC) is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges.

 

ITOC is organised by the WMA GmbH  in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munich (CCCM) in Munich.

 

The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.

See "Past Conferences"